Smart Money Alert

Glenmark Pharmaceuticals Limited

IncreasedQuarterly

GLENMARKHealthcareMarket Cap₹66K Cr

Stake

1.88% → 2.20%

Invesco Mutual Fund

Mutual Fund

The move

Invesco Mutual Fund increased its stake in Glenmark Pharmaceuticals from 1.88% to 2.20%, purchasing 903,000 shares for ₹202.04 crore at ₹2235.50 apiece.

About Glenmark Pharmaceuticals Limited

Visit stock

A global research-led pharmaceutical company, Glenmark operates across generics, specialty, and over-the-counter business segments with a presence in more than 80 countries worldwide. The company develops and manufactures pharmaceutical products serving patients across multiple therapeutic areas including oncology, dermatology, and respiratory care. Its distinctive strength lies in combining generic drug manufacturing capabilities with specialty pharmaceutical development and maintaining a robust international distribution network across developed and emerging markets.

About Invesco Mutual Fund

Visit investor

Indian subsidiary of Invesco Ltd, a US-listed global investment manager with over USD 1.8 trillion in AUM worldwide. Manages over Rs 1.2 lakh crore in India. Known for its Invesco India Contra Fund, which runs a contrarian, undervalued stock strategy against consensus market positioning. One of the few global AMC franchises maintaining a strong active equity presence in India.

Get the next move the moment it happens.

Follow Invesco Mutual Fund and Glenmark Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Glenmark Pharmaceuticals Limited shareholders Invesco Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Glenmark Pharmaceuticals Limited

Bandhan Mutual FundExited

Bandhan Mutual Fund has dropped from Glenmark Pharmaceuticals Limited's disclosed shareholder list after previously holding a 1.17 percent stake, indicating either a complete exit or a reduction below the 1 percent disclosure threshold.

19 Jul 2026

Government Pension Fund Global (Norway)Increased

Government Pension Fund Global (Norway) increased its stake in Glenmark Pharmaceuticals Limited from 3.78% to 3.89%, raising its shareholding from 10,674,228 to 10,985,826 shares. This change is worth ₹73.91 crore based on the current share price of ₹2301.30.